Presented by Mode Mobile: there’s a $2 start-up that might be well positioned to benefit from the upcoming SpaceX IPO. Click here to read more.

The selling is concentrated where it stings most. A high-flying chip bellwether posted its first revenue miss in over a year, and because the stock had run so hard into the print, even a small shortfall was enough to knock 15% off and rattle the broader AI trade.

The rest of the red tells a familiar story: companies getting punished for outlooks that simply were not good enough. An apparel heavyweight is in free fall after merely holding its guidance, a pet retailer slid on a soft forecast, and a premium software name disappointed despite guidance that technically cleared the bar. The handful of green names are leaning on analyst upgrades rather than blockbuster numbers. In this tape, standing still gets you sold.

Wall Street is preparing for what could become one of the biggest IPOs in market history.

SpaceX.

And if history tells us anything, when Elon Musk takes a company public…

It doesn't just create one winner.

It creates an entire ecosystem of winners around it.

When Tesla surged…

Battery suppliers exploded.

When Nvidia ran…

AI infrastructure stocks went parabolic.

When OpenAI went mainstream…

Data center and power companies soared 10x, 20x, even 50x.

Now investors are asking a different question:

If SpaceX IPOs… what industries could benefit next?

The answer?

We think Elon is going all-in on AI automation - because things running in space will need tech to operate perfectly on their own.

And we found a $2 startup positioned right at the center of it.

Specifically - investors that have at least $2,500 to work with have a chance to get in early BEFORE this company potentially goes public as well

How?

>>> If you have at least $2,500 to work with, get the company name and details by clicking here.*†

Best,
Invested Alpha

UnitedHealth (UNH): +3%

The health insurer is climbing after Bank of America upgraded it to buy from neutral. The bank pointed to improving medical cost trends and supportive near-term data, framing a favorable setup heading into second-quarter earnings. After a brutal stretch for managed care, any sign that the cost pressure is easing is enough to bring buyers back.

Medtronic (MDT): +2%

The medical-device maker got a buy rating from BTIG, which sees an attractive setup after Wednesday's earnings beat. The pitch is simple: the stock trades at a discount to peers, and the top line is set up to improve. For a name that has lagged, a cheap valuation plus a credible growth story is exactly what gets investors interested.

C3.ai (AI): +2%

The enterprise AI software company posted a narrower loss than Wall Street expected and slightly better revenue. It is a modest beat, but for a company that has spent the past year fighting questions about its growth, simply clearing the bar is enough to lift the stock.

PVH (PVH): -24%

The parent of Calvin Klein and Tommy Hilfiger is getting crushed despite a first-quarter earnings beat. The problem is the outlook: the company merely reiterated its full-year guidance while revenue landed roughly in line, and in a jittery tape, standing pat is not good enough. When a stock falls this hard on a beat, the market is telling you it wanted more.

Broadcom (AVGO): -15%

The chipmaker tumbled after revenue came up just short of estimates, its first quarterly miss since late 2024. The miss itself was small, but Broadcom had rallied hard into the print, and when a high-flying AI name finally stumbles, the air comes out fast.

Petco (WOOF): -13%

The pet retailer dropped after its current-quarter profit forecast came in below what Wall Street wanted. Guidance is the story here, and a soft outlook in a cautious consumer environment is enough to send shares lower.

CrowdStrike (CRWD): -10%

The cybersecurity company slipped on second-quarter guidance that failed to impress, even though its revenue forecast sat just above estimates. At CrowdStrike's premium valuation, investors are paying for upside, not in-line, so guidance that only matches expectations reads as a letdown.

Wall Street is preparing for what could become one of the biggest IPOs in market history.

SpaceX.

And if history tells us anything, when Elon Musk takes a company public…

It doesn't just create one winner.

It creates an entire ecosystem of winners around it.

When Tesla surged…

Battery suppliers exploded.

When Nvidia ran…

AI infrastructure stocks went parabolic.

When OpenAI went mainstream…

Data center and power companies soared 10x, 20x, even 50x.

Now investors are asking a different question:

If SpaceX IPOs… what industries could benefit next?

The answer?

We think Elon is going all-in on AI automation - because things running in space will need tech to operate perfectly on their own.

And we found a $2 startup positioned right at the center of it.

Specifically - investors that have at least $2,500 to work with have a chance to get in early BEFORE this company potentially goes public as well

How?

>>> If you have at least $2,500 to work with, get the company name and details by clicking here.*†

Best,
Invested Alpha

MannKind (MNKD)

Retail traders are circling MannKind ahead of the American Diabetes Association's 2026 Scientific Sessions, which kick off tomorrow in New Orleans and run through June 8. The company is presenting nine data sets on its inhaled insulin Afrezza, including late-breaking comparative data on June 7, and the chatter on StockTwits has turned bullish as traders position for the event.

The backdrop is a pending FDA decision on whether to approve Afrezza for children and adolescents, which would make it the first needle-free insulin option for pediatric patients in roughly a century. The stock has lagged this year, so a strong data showing or regulatory clarity could be the spark, though a clinical disappointment cuts the other way just as quickly.